Queen Mary University of London is playing a key role in major new European research initiative to combat Multi-Drug Resistant Rheumatoid Arthritis (MDR-RA)
The 100,000 Genomes Project: holding the key to 21st-century healthcare? William Harvey Research institute Professor Sir Mark Caulfield Vice Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry, Professor of Clinical Pharmacology
New genetic testing regime brings hope to adrenal insufficiency patients William Harvey Research institute Professor Lou Metherell Professor of Endocrine Genetics